List of Topics Print This Page

 Hematology

Drug-induced immune thrombocytopenia

Drug-induced immune thrombocytopenia


Definition:

Drug-induced immune thrombocytopenia is a condition in which the use of certain drugs leads to the formation of antibodies against clot-forming cells in the blood (platelets). These antibodies can cause a low platelet count, which makes bleeding more likely.

Causes, incidence, and risk factors:

If the antibodies to platelets form during pregnancy, they may pass from the mother to her unborn baby (fetus).


Review Date: 4/27/2007
Reviewed By: Rita Nanda, M.D., Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center, Chicago, IL. Review provided by VeriMed Healthcare Network.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2002 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

  View History
 Drug-induced immune thrombocytopenia

   
   

 

About UPHS   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

The University of Pennsylvania Health System, Philadelphia, PA 1-800-789-PENN © 2008, The Trustees of the University of Pennsylvania